marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Armata Pharmaceuticals Financial Ratios 2011-2024 | ARMP
Annual Financial Ratios Armata Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.9 | -1.8 | -5.1 | -4.1 | -1.3 | -0.4 | -0.6 | -0.2 | -31.5 | 1.5 | -1.1 | -6.1 | -2.6 |
P/S |
- | - | - | 109.7 | - | - | 67.2 | 17.4 | 34.2 | 82.4 | 196.2 | 10.1 | 81.7 |
EPS |
-1.9 | -1.1 | -1.0 | -1.4 | -2.5 | -3.6 | -2.0 | -24.7 | -2.0 | 4.2 | -0.6 | - | - |
EV (Enterprise Value) |
250 M | 110 M | 151 M | 101 M | 29.7 M | 1.23 K | 6 M | 7.29 M | 25.6 M | 52.3 M | 95.6 M | 15.9 M | 14.1 M |
EBITDA per Share |
-1.11 | -1.05 | -0.94 | -1.11 | -2.65 | -7.53 | -21.9 | -192 | -256 | -521 | -1.03 K | -573 | -383 |
EV/EBITDA |
-5.8 | -4.0 | -1.1 | 0.3 | -0.3 | 0.0 | -0.7 | -1.9 | -2.9 | -2.4 | -3.0 | ||
PEG |
0.08 | 0.05 | 0.09 | -0.09 | -0.02 | -0.01 | -0.01 | 0.01 | 0.24 | 0.01 | 0.0 | -0.1 | -0.03 |
P/B |
-4.2 | 1.8 | 4.6 | 4.8 | 1.7 | 0.6 | 1.0 | 0.5 | 1.3 | 9.8 | -4.5 | 0.5 | 1.4 |
P/CF |
-2.8 | -2.0 | -5.0 | -4.7 | -1.6 | -0.5 | -0.8 | -0.4 | -1.6 | -2.4 | -8.4 | -1.6 | -2.1 |
ROE % |
215.33 | -102.32 | -91.17 | -117.63 | -133.48 | -142.91 | -166.06 | -193.75 | -4.06 | 672.36 | 410.74 | -8.58 | -53.01 |
ROA % |
-70.19 | -38.52 | -33.19 | -56.13 | -76.54 | -101.88 | -115.26 | -103.53 | -1.64 | 80.75 | -153.93 | -5.03 | -33.01 |
ROCE % |
127.52 | -102.40 | -93.80 | -65.79 | -92.79 | -113.73 | -112.93 | -94.64 | -35.13 | -52.75 | -41.86 | -25.12 | -39.22 |
Current Ratio |
0.8 | 1.6 | 1.6 | 1.6 | 1.4 | 3.3 | 2.7 | 1.8 | 4.2 | 3.8 | 9.6 | 0.3 | 1.1 |
DSO |
- | - | - | 248.8 | - | - | - | 35.1 | 96.1 | 89.2 | 9.0 | 352.4 | 365.0 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Armata Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.15 | 0.25 | -0.69 | - | -0.86 | -0.1 | -0.4 | - | -0.24 | -0.26 | -0.3 | - | -0.22 | -0.25 | -0.27 | - | -0.31 | -0.26 | -0.49 | - | -0.73 | -0.56 | -0.11 | - | -0.6 | -0.68 | -0.24 | - | -0.09 | -1.21 | -1.94 | -0.7 | -3.23 | -7.26 | -0.82 | -0.54 | -0.3 | 1.27 | -3.49 | -0.25 | 3.87 | 2.56 | -3.18 | - | -0.49 | -0.16 | -0.64 | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.26 | -0.32 | -0.27 | - | -0.28 | -0.26 | -0.31 | - | -0.23 | -0.25 | -0.29 | - | -0.24 | -0.24 | -0.25 | - | -0.29 | -0.23 | -0.44 | - | -0.67 | -0.64 | -0.1 | - | -0.45 | -0.52 | -0.22 | - | -0.06 | -1.78 | -1.95 | -7.2 | -2.84 | -3.93 | -0.76 | -0.5 | -0.38 | -0.44 | -0.52 | -0.65 | -1.38 | -1 | -0.01 | - | -0.02 | -0.07 | -0.12 | - | - | - | - | - | - | - | - |
ROE % |
287.12 | 527.95 | 528.91 | 168.50 | 149.60 | -120.88 | -119.64 | -50.45 | -73.26 | -77.17 | -81.52 | -60.61 | -91.20 | -98.99 | -102.32 | -82.50 | -130.16 | -147.23 | -151.02 | -102.06 | -138.07 | -126.43 | -138.81 | -114.16 | -124.24 | -98.30 | -140.71 | -135.64 | -233.34 | -247.69 | -203.73 | -193.75 | -113.59 | -93.22 | -57.67 | -29.72 | -31.49 | 644.92 | 1321.34 | 1997.76 | 2302.53 | 1915.62 | 1528.71 | 856.35 | 856.35 | 570.90 | 285.45 | - | - | - | - | - | - | - | - |
ROA % |
-45.71 | -67.76 | -79.56 | -44.46 | -53.73 | -35.37 | -40.99 | -26.54 | -39.24 | -42.67 | -46.37 | -35.93 | -50.53 | -52.43 | -51.52 | -39.37 | -66.70 | -79.42 | -84.00 | -58.52 | -77.57 | -69.29 | -74.57 | -67.19 | -74.18 | -62.13 | -98.36 | -94.15 | -146.48 | -152.57 | -115.77 | -103.73 | -58.49 | -47.04 | -27.46 | -12.00 | -7.24 | 75.16 | 157.55 | 239.94 | 85.55 | -151.91 | -389.36 | -470.12 | -470.12 | -313.41 | -156.71 | - | - | - | - | - | - | - | - |
ROCE % |
- | - | - | - | -18.92 | -37.84 | -55.14 | -50.48 | -76.34 | -83.28 | -87.63 | -63.49 | -93.31 | -97.27 | -99.96 | -80.26 | -126.70 | -143.32 | -154.32 | -105.37 | -136.94 | -122.07 | -123.67 | -104.57 | -114.22 | -92.30 | -180.64 | -178.39 | -300.41 | -325.80 | -237.42 | -240.44 | -141.54 | -125.60 | -109.08 | -80.44 | -132.87 | -133.29 | -119.97 | -105.62 | -38.28 | -26.98 | -41.41 | -74.92 | -74.92 | -66.70 | -45.20 | - | - | - | - | - | - | - | - |
Current Ratio |
0.7 | 0.7 | 0.7 | 0.8 | 0.9 | 1.2 | 1.3 | 1.6 | 2.0 | 2.1 | 2.3 | 1.6 | 2.3 | 2.5 | 2.8 | 1.9 | 1.9 | 1.9 | 1.9 | 2.3 | 2.3 | 2.3 | 2.3 | 2.1 | 2.1 | 2.1 | 3.5 | 3.3 | 3.3 | 3.3 | 3.3 | 2.1 | 2.1 | 2.1 | 2.1 | 4.6 | 4.6 | 4.6 | 4.6 | 1.2 | 1.2 | 1.2 | 1.2 | 0.7 | 0.7 | 0.7 | 0.7 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency